Our Services

Comprehensive advisory solutions across the healthcare value chain — from deal advisory to operational excellence.

1. Deal Advisory & Investment Support

Providing specialist advisory across transactions, investments, and capital markets in healthcare with deep sector intelligence.

M&A and Investment Advisory

Providing sell-side due diligence, transaction support, and deep sector expertise for corporate finance activities. Our team navigates the complexities of healthcare M&A with precision, ensuring optimal outcomes for buyers and sellers alike.

Rapid Due Diligence

Tech-enabled assessment for PE/VC investors targeting healthcare sub-segments. Our rapid due diligence framework delivers actionable insights in compressed timelines without compromising depth or accuracy.

Asset Shortlisting

Mapping the healthcare universe to identify high-growth investment targets (e.g., IVF, Oncology, Diagnostics). We build systematic screening frameworks that surface the most attractive opportunities aligned with investor mandates.

Investment Banking & Capital Raising

Leveraging a robust network of 800+ PE/VC firms and family offices to fuel growth. We manage end-to-end capital raising cycles — from investor readiness and pitch decks to term sheet negotiation and deal closure.


2. Commercial Due Diligence (CDD)

In-depth market intelligence and competitive assessment for healthcare assets — both buy-side and sell-side.

Market-Level Intelligence

Rigorous buy-side and sell-side due diligence to validate market size and growth potential across healthcare sub-segments.

Competitive Benchmarking

Deep-dive analysis of competitor positioning, pricing strategies, and operational performance across healthcare delivery and diagnostics.

Growth Validation

Auditing historical performance and stress-testing future revenue projections for healthcare delivery and MedTech assets.

Risk Mitigation

Identifying regulatory hurdles and micro-market challenges that could impact asset valuation and investment thesis.


3. Strategy & Growth

Identifying new growth markets, defining GTM strategies, and driving patient acquisition through data-driven approaches.

New Business Strategy & GTM

Identifying new growth markets and defining Go-To-Market strategies with market validation. Product launch blueprints for new pharmaceutical molecules, medical devices, and healthtech platforms.

Micro-market Assessment

Granular, local-level analysis of demand and competition to optimize network expansion. Identifying specific geographic “white spaces” for clinic, hospital, and diagnostic center growth.

Patient Acquisition

Data-driven strategies for targeted engagement and loyalty to increase patient inflow. Implementing digital and physical engagement models to maximize patient volume through B2B channel strategy and sales force optimization.

Exports & International Expansion

Strategic roadmaps for global market entry, including regulatory navigation and geography selection. Building frameworks for MedTech export readiness and international commercial deployment.


4. Operational & Financial Excellence

Surgical process optimization to eliminate inefficiencies and improve profitability across the healthcare value chain.

Margin Transformation

Surgical process optimization to eliminate inefficiencies and improve profitability across the value chain. Identifying and unlocking hidden margin opportunities in healthcare delivery and diagnostics.

Diagnostic Pricing & Test Costing

Precision pricing strategies based on true cost-to-serve analysis. Building robust pricing architectures that balance competitive positioning with margin sustainability across diagnostic portfolios.

Supply Chain Transformation

Streamlining procurement, logistics, and inventory to build resilience and reduce turnaround times. End-to-end supply chain redesign for healthcare delivery and MedTech manufacturers.

Local Manufacturing Strategy

Optimizing production footprints and sourcing frameworks, particularly for MedTech. Local manufacturing feasibility assessments and make-vs-buy analysis for healthcare products.

Sub-Vertical Focus Areas

Sub-VerticalKey Focus
DiagnosticsUnlocking hidden margins, commercial model redefinition, and testing cost optimization.
Healthcare DeliveryDigital transformation for hospitals, end-to-end efficiency, and hospital network expansion.
MedTechCommercial excellence, sales force optimization, and winning category GTM strategies.

Discuss Your Requirements

Connect with our specialists to explore how PSTRIDE can support your healthcare business objectives.

Scroll to Top